[1] |
宋杨, 姜孟楠, 魏强. 加强和推进传染性疾病样本资源库建设. 中国科学(生命科学), 2024, 54(6):1082-1087. doi:10.1360/SSV-2023-0142.
|
[2] |
Peng H, Bilal M, Iqbal HMN. Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks. Int J Environ Res Public Health, 2018, 15(12):2697. doi:10.3390/ijerph15122697.
|
[3] |
World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization, 2024.
|
[4] |
Li T, Yan X, Du X, et al. Extrapulmonary tuberculosis in China: a national survey. Int J Infect Dis, 2023, 128:69-77. doi:10.1016/j.ijid.2022.12.005.
|
[5] |
Meehan CJ, Goig GA, Kohl TA, et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol, 2019, 17(9):533-545. doi:10.1038/s41579-019-0214-5.
pmid: 31209399
|
[6] |
Merker M, Kohl TA, Niemann S, et al. The Evolution of Strain Typing in the Mycobacterium tuberculosis Complex. Adv Exp Med Biol, 2017, 1019:43-78. doi:10.1007/978-3-319-64371-7_3.
|
[7] |
Gagneux S. Ecology and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol, 2018, 16(4):202-213. doi:10.1038/nrmicro.2018.8.
|
[8] |
Stanley S, Spaulding CN, Liu Q, et al. Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strains. Lancet Microbe, 2024, 5(6):e570-e580. doi:10.1016/S2666-5247(24)00022-3.
pmid: 38734030
|
[9] |
Kanabalan RD, Lee LJ, Lee TY, et al. Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery. Microbiol Res, 2021, 246:126674. doi:10.1016/j.micres.2020.126674.
|
[10] |
Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res, 2020, 152(3):185-226. doi:10.4103/ijmr.IJMR_902_20.
|
[11] |
Deqing L, Khan MT, Yaoju T, et al. Increasing trends of non-tuberculous mycobacteria clinical isolates in Guangzhou, China. Acta Trop, 2024, 260:107398. doi:10.1016/j.actatropica.2024.107398.
|
[12] |
Conyers LE, Saunders BM. Treatment for non-tuberculous mycobacteria: challenges and prospects. Front Microbiol, 2024, 15:1394220. doi:10.3389/fmicb.2024.1394220.
|
[13] |
国家疾病预防控制局, 国家发展和改革委员会, 教育部, 等. 关于印发《全面消除麻风危害可持续发展规划(2024—2030年)》的通知. 2024-01-23.
|
[14] |
邓星超. 麻风病低流行期防治对策探讨. 2019年全国麻风皮肤病学术年会论文集, 大连, 2019. 北京: 中国麻风病防治协会, 2019.
|
[15] |
刘珏, 刘民. 关注传染病流行,防范跨境传播风险. 中华流行病学杂志, 2022, 43(7):1049-1052. doi:10.3760/cma.j.cn112338-20220125-00073.
|
[16] |
Islam MR, Sharma MK, KhunKhun R, et al. Whole genome sequencing-based identification of human tuberculosis caused by animal-lineage Mycobacterium orygis. J Clin Microbiol, 2023, 61(11):e0026023. doi:10.1128/jcm.00260-23.
|
[17] |
World Health Organization. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. 2nd ed. Geneva: World Health Organization, 2023.
|
[18] |
李志丽, 刘宇红. 《世界卫生组织结核病整合指南模块6:结核病及其共患病-HIV》解读. 中国防痨杂志, 2024, 46(8):869-873. doi:10.19982/j.issn.1000-6621.20240225.
|
[19] |
卢水华. 关注结核病共患病已成为公共卫生的需要. 结核与肺部疾病杂志, 2022, 3(4):255-260. doi:10.19983/j.issn.2096-8493.20220107.
|
[20] |
Ding XY, Li SS, Geng YM, et al. Programmable Base Editing in Mycobacterium tuberculosis Using an Engineered CRISPR RNA-Guided Cytidine Deaminase. Front Genome Ed, 2021, 3:734436. doi:10.3389/fgeed.2021.734436.
|
[21] |
Alonso MN, Malaga W, Mc Neil M, et al. Efficient method for targeted gene disruption by homologous recombination in Mycobacterium avium subspecie paratuberculosis. Res Microbiol, 2020, 171(5-6):203-210. doi:10.1016/j.resmic.2020.04.001.
pmid: 32283218
|
[22] |
Moraes L, Trentini MM, Fousteris D, et al. CRISPR/Cas 9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tuberculosis Vaccine Candidate. Front Immunol, 2022, 13:867195. doi:10.3389/fimmu.2022.867195.
|
[23] |
Pei S, Song Z, Yang W, et al. The catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: a genomic analysis. Lancet Microbe, 2024, 5(11):100899. doi:10.1016/S2666-5247(24)00131-9.
|
[24] |
Perdigão J, Silva H, Machado D, et al. Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting. BMC Genomics, 2014, 15(1):991. doi:10.1186/1471-2164-15-991.
|
[25] |
Sreevatsan S, Pan X, Stockbauer KE, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A, 1997, 94(18):9869-9874. doi:10.1073/pnas.94.18.9869.
|
[26] |
Liu Q, Zhu J, Dulberger CL, et al. Tuberculosis treatment failure associated with evolution of antibiotic resilience. Science, 2022, 378(6624):1111-1118. doi:10.1126/science.abq2787.
pmid: 36480634
|
[27] |
Wilson DJ, CRyPTIC Consortium. GenomegaMap: Within-Species Genome-Wide dN/dS Estimation from over 10,000 Genomes. Mol Biol Evol, 2020, 37(8):2450-2460. doi:10.1093/molbev/msaa069.
pmid: 32167543
|
[28] |
Liu D, Huang F, Li Y, et al. Transmission characteristics in Tuberculosis by WGS: nationwide cross-sectional surveillance in China. Emerg Microbes Infect, 2024, 13(1):2348505. doi:10.1080/22221751.2024.2348505.
|
[29] |
Zhao B, Liu C, Fan J, et al. Transmission and Drug Resis-tance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China. Microbiol Spectr, 2022, 10(5):e0240521. doi:10.1128/spectrum.02405-21.
|
[30] |
Walker TM, Choisy M, Dedicoat M, et al. Mycobacterium tuberculosis transmission in Birmingham, UK, 2009-19: An observational study. Lancet Reg Health Eur, 2022, 17:100361. doi:10.1016/j.lanepe.2022.100361.
|
[31] |
Del Río JS, Svobodova M, Bustos P, et al. Electrochemical detection of Piscirickettsia salmonis genomic DNA from salmon samples using solid-phase recombinase polymerase amplification. Anal Bioanal Chem, 2016, 408(30):8611-8620. doi:10.1007/s00216-016-9639-0.
pmid: 27220649
|
[32] |
Lyu L, Li Z, Pan L, et al. Evaluation of digital PCR assay in detection of M.tuberculosis IS6110 and IS1081 in tuberculosis patients plasma. BMC Infect Dis, 2020, 20(1):657. doi:10.1186/s12879-020-05375-y.
|
[33] |
Cai Y, Dai Y, Wang Y, et al. Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis. EBioMedicine, 2020, 53:102686. doi:10.1016/j.ebiom.2020.102686.
|
[34] |
Qiu X, Zhong P, Yue L, et al. Spatial transcriptomic sequencing reveals immune microenvironment features of Mycobacterium tuberculosis granulomas in lung and omentum. Theranostics, 2024, 14(16):6185-6201. doi:10.7150/thno.99038.
|
[35] |
Barbier M, Wirth T. The Evolutionary History, Demography, and Spread of the Mycobacterium tuberculosis Complex. Microbiol Spectr, 2016, 4(4). doi:10.1128/microbiolspec.TBTB2-0008-2016.
|
[36] |
Chen H, He L, Cai C, et al. Characteristics of distribution of Mycobacterium tuberculosis lineages in China. Sci China Life Sci, 2018, 61(6):651-659. doi:10.1007/s11427-017-9243-0.
|
[37] |
Zakham F, Sironen T, Vapalahti O, et al. Pan and Core Genome Analysis of 183 Mycobacterium tuberculosis Strains Revealed a High Inter-Species Diversity among the Human Adapted Strains. Antibiotics (Basel), 2021, 10(5):500. doi:10.3390/antibiotics10050500.
|
[38] |
Negrete-Paz AM, Vázquez-Marrufo G, Vázquez-Garcidueñas MS. Whole-genome comparative analysis at the lineage/sublineage level discloses relationships between Mycobacterium tuberculosis genotype and clinical phenotype. PeerJ, 2021, 9:e12128. doi:10.7717/peerj.12128.
|
[39] |
Liu Z, Li W, Zhang Y, et al. Analysis of Clinical Factors, Bacterial Genotyping, and Drug Resistance for Spinal Tuberculosis in South-Central China. Biomed Res Int, 2020, 2020:9871390. doi:10.1155/2020/9871390.
|
[40] |
袁伟, 秦川. 结核病动物模型研究进展. 中国比较医学杂志, 2010, 20(9):55-59.
|
[41] |
Verkhivker G, Alshahrani M, Gupta G, et al. From Deep Mutational Mapping of Allosteric Protein Landscapes to Deep Learning of Allostery and Hidden Allosteric Sites: Zooming in on “Allosteric Intersection” of Biochemical and Big Data Approaches. Int J Mol Sci, 2023, 24(9):7747. doi:10.3390/ijms24097747.
|
[42] |
国家疾病预防控制局, 国家卫生健康委员会, 国家发展和改革委员会, 等. 关于印发《全国结核病防治规划(2024—2030年)》的通知. 国疾控传防发〔2024〕19号. 2025-11-28.
|
[43] |
Hamilton CD, Swaminathan S, Christopher DJ, et al. RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration. Clin Infect Dis, 2015, 61Suppl 3(Suppl 3):S155-S159. doi:10.1093/cid/civ611.
|